Powder: -20°C for 3 years | In solvent: -80°C for 1 year
Saterinone is a potent and selective phosphodiesterase III inhibitor and a potent antagonist of the vascular α-1-adrenoceptor. Saterinone has vasodilatory properties and can be used in the acute treatment of chronic heart failure. Saterinone inhibited crude cAMP phosphodiesterase (PDE) activity in guinea pig right ventricular homogenates The ic50 value is 2.3 × 10(-5) mol/l.
Pack Size | Availability | Price/USD | Quantity |
---|---|---|---|
1 mg | In stock | $ 158.00 | |
5 mg | In stock | $ 390.00 | |
10 mg | In stock | $ 590.00 | |
25 mg | In stock | $ 943.00 | |
50 mg | In stock | $ 1,280.00 | |
100 mg | In stock | $ 1,730.00 | |
500 mg | In stock | $ 3,460.00 | |
1 mL * 10 mM (in DMSO) | In stock | $ 459.00 |
Description | Saterinone is a potent and selective phosphodiesterase III inhibitor and a potent antagonist of the vascular α-1-adrenoceptor. Saterinone has vasodilatory properties and can be used in the acute treatment of chronic heart failure. Saterinone inhibited crude cAMP phosphodiesterase (PDE) activity in guinea pig right ventricular homogenates The ic50 value is 2.3 × 10(-5) mol/l. |
Targets&IC50 | Isoenzyme III:0.06 mumol/l, Pig papillary muscles:9.1 mumol/l(EC50) |
In vitro | Saterinone selectively and potently inhibited the isoenzyme III of PDE (IC50 = 0.06 mumol/l). Thus, saterinone proved to be a selective inhibitor of 'low-Km, cAMP specific' PDE III.[1] |
In vivo | Saterinone (1-30 mumol/l) exerted a concentration-dependent positive inotropic effect (EC50 = 9.1 mumol/l) in guinea pig papillary muscles.[1] |
Molecular Weight | 474.55 |
Formula | C27H30N4O4 |
CAS No. | 102669-89-6 |
Powder: -20°C for 3 years | In solvent: -80°C for 1 year
DMSO: 4.75 mg/mL (10 mM)
You can also refer to dose conversion for different animals. More
bottom
Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc.
Saterinone 102669-89-6 GPCR/G Protein Metabolism Neuroscience Adrenergic Receptor PDE inhibitor inhibit